Financials data is unavailable for this security.
View more
Year on year Korro Bio Inc had revenues remain flat at 0.00, though the company grew net income from a loss of 81.58m to a smaller loss of 81.17m.
Gross margin | -- |
---|---|
Net profit margin | -- |
Operating margin | -- |
Return on assets | -56.06% |
---|---|
Return on equity | -75.75% |
Return on investment | -59.82% |
More ▼
Cash flow in USDView more
In 2023, Korro Bio Inc increased its cash reserves by 317.39%, or 131.64m. Cash Flow from Financing totalled 187.76m or -- of revenues. In addition the company used 67.28m for operations while cash from investing totalled 11.16m.
Cash flow per share | -16.34 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 21.34 |
---|---|
Tangible book value per share | 21.34 |
More ▼
Balance sheet in USDView more
Current ratio | 13.28 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼